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Decidual, Amniotic Fluid, Maternal and Fetal 
Prolactin in Normal and Abnormal Pregnancies 
ANTHONY A. LUCIANO, MD, AND MICHAEL W. VARNER, MD 
In the present studies, the content and the in vitro produc-
tion of prolactin by decidua as well as the concentrations of 
prolactin in amniotic fluid, maternal and fetal serum in 
normal term pregnancies, induced abortions at various ges-
tational ages, and in pregnancies complicated by diabetes 
mellitus, preeclampsia, chronic hypertension, and polyhy-
dramnios were measured. Maternal and fetal prolactin lev-
els varied considerably throughout gestation, but at term did 
not differ significantly between normal and abnormal preg-
nancies. Prolactin levels in amniotic fluid as well as decidu-
al prolactin content and production were significantly lower 
only in pregnancies complicated by either hypertension or 
polyhydramnios. In both normal and abnormal pregnancies, 
decidual prolactin production correlated strongly with am-
niotic fluid concentrations. The present data suggest that 1) 
maternal and fetal prolactin levels do not differ significantly 
between normal and abnormal pregnancies, 2) the decidua is 
the principal source of amniotic fluid prolactin, and 3) the 
significantly lower levels of prolactin in amniotic fluid of 
pregnancies complicated by hypertension or polyhydram-
nios are probably due to adverse effects of these conditions 
on the synthesis and release of prolactin by decidua. (Obstet 
Gynecol 63:384, 1984) 
During normal human pregnancy, the prolactin levels 
in amniotic fluid and maternal and fetal serum reach 
the highest physiologic concentrations, with amniotic 
fluid levels being the greatest by far. 1-3 Although the 
biologic significance of this is not yet known, abnormal 
amniotic fluid prolactin concentrations have been 
reported to be associated with some pathological situa-
tions in which amniotic fluid volumes and fetal hydra-
tion are affected. 4,5 In addition, pregnancies complicat-
ed by hypertension have been reported by some 
authors to have abnormal maternal and fetal prolactin 
levels6 ,7 while others have reported similar prolactin 
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levels between normal and hypertensive pregnan-
cies. 8 ,9 The sources of the circulating maternal and fetal 
prolactin are believed to be their respective pituitary 
glands, whereas the major source of prolactin in amni-
otic fluid is believed to be the decidua that lines the 
pregnant uterus. 1(}'-12 A positive correlation between 
decidual prolactin and the concentrations of prolactin 
in amniotic fluid has recently been described in normal 
pregnancies,12 but in abnormal pregnancies no infor-
mation is available regarding decidual prolactin secre-
tion and its relation to amniotic fluid prolactin levels. 
Because of the previously mentioned controversies 
and the lack of information regarding decidual prolac-
tin in pathological pregnancies, the authors have mea-
sured the concentration of prolactin in amniotic fluid, 
maternal and fetal serum, and determined the prolac-
tin content and the in vitro production of prolactin by 
decidua in both normal pregnancies and pregnancies 
complicated by preeclampsia, diabetes mellitus, chron-
ic hypertension, and polyhydramnios, 
Materials and Methods 
Appropriate informed consent, as approved by the 
Human Subject Review Committee of the University of 
Iowa College of Medicine, was obtained from all partic-
ipants of this study, which included 20 women under-
going first-trimeter suction abortion (six to 16 weeks' 
gestation), 30 women undergoing second-trimester sa-
line abortion (17 to 21 weeks' gestation), 30 women 
with normal, uncomplicated pregnancies, and ten 
women each with preeclampsia, insulin-dependent 
diabetes mellitus, chronic hypertension, and polyhy-
dramnios. All diabetic patients were under the care of 
one of the authors (MWV), who controlled blood 
glucose strictly with two injections of insulin per day to 
achieve fasting blood levels between 70 and 110 
mg/lOO ml and postprandial levels between 80 and 130 
mg/100 ml. All hypertensive patients had been diag-
nosed and treated for essential hypertension before 
pregnancy. Although the majority of them had been 
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Figure 1. Mean (± SEM) maternal serum prolactin concentrations 
during the first and second trimesters of pregnancy. and in normal 
and abnormal pregnancies at term. Term: NP = normal; PRE = 
preeclampsia; DM = diabetes mellitus; HYP = chronic hypertension; 
PH = polyhydramnios. 
on antihypertensive medication before and sometimes 
during pregnancy, only three of these patients were on 
antihypertensive medication at the time of admission 
into the labor and delivery unit. One patient was 
taking a-methyldopa, 2 g/day, and the other two 
patients were taking a-methyldopa, 1 g/day and hy-
drochlorothiazide, 50 mg/day. The diagnosis of poly-
hydramniOS, with amniotic fluid volumes estimated at 
greater than 2000 ml, was made clinically in all patients 
with excessive uterine enlargement associated with 
difficulty in palpating fetal parts. Seven of these pa-
tients underwent ultrasonographic studies that con-
firmed the clinical diagnOSis, and three patients under-
went amniocentesis during the latter part of the third 
trimester with removal of excess amniotic fluid to 
relieve maternal discomfort. Four of the patients with 
polyhydramnios also had insulin-dependent diabetes 
mellitus, but they were not included in the group of 
patients with diabetes mellitus. No other causes for 
polyhydramnios were evident in the other patients. 
The preeclampsia was mild to severe in these pa-
. tients, and all were treated with intravenous magne-
sium sulfate from 12 to 36 hours before delivery. 
Except for abortions, only pregnancies of greater than 
36 weeks' gestation with normal infants were included 
in the study to avoid differences that might have been 
attributed to fetal maturity or fetal abnormalities. 
Sampies of maternal peripheral blood, fetal cord 
blood, amniotic fluid, and decidual explants were 
obtained during the immediate peripartum period. 
The serum and amniotic fluid samples were frozen and 
: stored until assayed for prolactin in the same batch to 
avoid interassay variability. Decidual content and pro-
duction of prolactin were measured before and after 
24-hour incubation of 300-mg samples of freshly ob-
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tained explants of decidua dissected from the maternal 
surface of the chorion immediately after delivery of the 
placenta. 13 Prolactin concentrations were measured by 
speCific radioimmunoassay based on the technique of 
Sinha et al,14 and the mean intraassay variability was 
7.5%. The statistical analyses of results were per-
formed by the Student t test and linear regression 
analyses. 
Results 
Figure 1 shows maternal serum prolactin levels 
throughout pregnancy and at term in normal and 
abnormal pregnancies. As reported, 1-3 maternal 
serum prolactin concentrations increase progressively 
throughout gestation, reaching the highest levels after 
the 36th week of pregnancy. At term, although mater-
nal prolactin levels varied considerably from patient to 
patient, they did not differ significantly between nor-
mal and abnormal pregnancies. Similarly, fetal prolac-
tin levels from normal pregnancies did not differ from 
abnormal pregnancies at term. Figure 2 shows the 
mean prolactin concentrations in amniotic fluid 
throughout gestation in normal pregnancies, and after 
36 weeks of abnormal pregnancies. 
Amniotic fluid prolactin levels were highest between 
17 and 20 weeks' gestation (P < .01). After 36 weeks' 
gestation, they declined to levels similar to those 
obtained during the first trimester. At term, the amni-
otic fluid prolactin levels in pregnancies complicated 
by chronic hypertension or polyhydramnios were sig-
nificantly lower than normal pregnancies or pregnan-
cies complicated by either diabetes mellitus or pre-
eclampsia (P < .01). 
Figure 3 shows decidual prolactin content and pro-
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Figure 2. Mean (± SEM) prolactin concentrations in amniotic fluid 
during the first and second trimesters of pregnancy. and in normal 
and abnormal pregnancies at term. 'Significantly different from 
normal pregnancies (p < .01 by Student t test). Abbreviations as in 
Figure 1. 









As with amniotic fluid prolactin levels, decidual pro-
lactin content and production in pregnancies compli-
cated by either chronic hypertension or polyhydram-
nios were significantly lower than normal pregnancies 
and pregnancies complicated by diabetes mellitus or 
preeclampsia (P <:: .01). 
Because the initial content of prolactin in decidua 
seemed to parallel the amount of prolactin produced 
after 24 hours' incubation, correlation analyses were 
carried out between initial prolactin content and pro-
duction after 24-hour incubation. Significant correla-
tions were found between the initial tissue content of 
prolactin and its production in both normal (r = .559, 
P < .001) and abnormal pregnancies (r = .499, P = 
.00104). This suggests that the capacity of the decidua 
to produce prolactin in vitro can be predicted from its 
initial content. 
To further test the hypothesis that the decidua is a 
major source of amniotic fluid prolactin, regression 
analyses were carried out between the amount of 
prolactin produced by the decidua after 24-hour incu-
bation in vitro and prolactin concentrations in the 
amniotic fluid of normal and abnormal pregnancies. 
These correlations were highly significant, as shown in 
Figures 4 and 5, further supporting the hypothesis that 
the decidua is the major source of prolactin in amniotic 
fluid. 
Discussion 
Besides preparing the breast for lactation, the biologic 
roles of the high levels of prolactin in human pregnan-
cy remain speculative. Because prolactin has been 
reported to antagonize the pressor effects of angioten-
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Figure 3. Mean (= SEM) prolactin content (black columns) and 
production (white columns) by decidua in normal and abnormal 
pregnancies at term. 'Significantly different from normal pregnancies 
(P < .01 by Student t test). Abbreviations as in Figure 1. 
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Figure 4. Correlation of decidual production of prolactin (DP PRL) 
in vitro and amniotic fluid prolactin (AF PRL) concentrations in 
normal pregnancies. r = .711; P < .001. 
has been postulated that the high levels of prolactin 
during pregnancy may be protective against the devel-
opment of hypertension, and that gestational hyper-
tension may develop in patients with decreased prolac-
tin levels. 17 Although Yuen et al6 reported decreased 
maternal plasma prolactin levels in pregnant women 
with either preeclampsia or chronic hypertension, no 
difference in maternal prolactin levels between normal 
and hypertensive pregnant women or pregnancies 
complicated by diabetes mellitus or polyhydramnios 
have been found in this and other studies.8,9 There-
fore it seems that maternal prolactin levels in preg-
nancy are not helpful in the evaluation of pathological 
pregnancies. 
Fetal prolactin may be important in fetal lung matu-
ration during the latter part of pregnancy.7-18 In the 
present study, cord prolactin levels did not differ 
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Figure 5. Correlation of decidual production of prolactin (DP pr,L) 
in vitro and amniotic fluid prolactin (AF PRL) concentrations in 
abnormal pregnancies. r = .480; P = .002. 

























ae reported that cord prolactin levels in infants of 
preeclamptic and hypertensive women were higher 
than in infants of normotensive women delivered 
between 30 and 39 weeks of gestation, but the differ-
ences were insignificant at later gestational ages. The 
failure to find any differences in cord prolactin levels 
between normal and abnormal pregnancies after 36 
weeks' gestation may be due to the relatively small 
number of patients in each of the abnormal groups or 
to the fact that the present study included only full-
term pregnancies with completely normal infants, thus 
avoiding differences that might be attributed to prema-
turity and/or fetal anomalies. 
In agreement with previous reports,I-3 the amniotic 
fluid prolactin levels in these studies were several 
times higher than either maternal or fetal levels, with 
the highest concentrations occurring at midgestation. 
Although amniotic fluid prolactin levels from patients 
with diabetes mellitus or preeclampsia did not differ 
from those in patients with normal pregnancies at 
term, patients with chronic hypertension or polyhy-
dramnios had amniotic fluid prolactin concentrations 
significantly lower than normal. Similar findings have 
been reported by Freisen et a14 and Josimovich5 in 
small numbers of patients with polyhydramnios, and 
by Yuen et a16 in patients with chronic hypertension. 
The decreased amniotic fluid prolactin levels in pa-
tients with polyhydramnios could be attributed to 
either a dilutional effect or to a decreased transfer of 
prolactin from either maternal or fetal serum. But the 
present findings that decidual prolactin content and 
production are similarly reduced in pregnancies com-
plicated by either chronic hypertension or polyhy-
dramnios suggest that the underlying dysfunction lies 
with the decidua. The report by Rosenberg et al l2 of a 
high correlation between decidua prolactin content 
and production with amniotic fluid prolactin concen-
trations observed in the present studies in both normal 
and abnormal pregnancies strongly support the con-
clusion that the decidua is the most important source 
of prolactin in amniotic fluid. Therefore, the decreased 
prolactin production by decidua is most likely respon-
sible for the decreased levels of amniotic fluid prolactin 
observed in pregnancies complicated by polyhydram-
nios or chronic hypertension. What causes the decidua 
from these pregnancies to produce less prolactin is not 
known. It is possible that in chronic hypertension the 
vascular supply to the endometrium may be dimin-
ished, causing the decidua to be less productive. The 
reaSOn similar changes were not observed in pre-
eclamptic women may be related to the duration of the 
vascular compromise, which is much longer in chronic 
hypertension than in preeclamptic patients. Prolactin 
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production by decidua of pregnancies complicated by 
polyhydramnios may be adversely affected by either 
the increased intrauterine pressure or the excessive 
stretching of the decidua by the greatly enlarged 
uterus. However, these are merely speculations and 
need to be further evaluated. 
In conclusion, the authors' findings revealed that: 1) 
maternal and fetal prolactin levels, although varying 
considerably throughout gestation, do not differ signif-
icantly between normal and abnormal pregnancies; 2) 
amniotic fluid prolactin levels correlate with decidua 
prolactin content and secretion in both normal and 
abnormal pregnancies, and differ from normal only in 
those pregnancies complicated by chronic hyperten-
sion and polyhydramnios; and 3) the strong correla-
tions of decidua prolactin production with amniotic 
fluid prolactin concentrations in both normal and ab-
normal pregnancies further support the concept that 
the decidua is the principal source of amniotic fluid 
prolactin. 
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